High expression of CXCL5 in tumor tissues was positively associated with an advanced T stage (p=0.036), positive lymph node metastasis (p=0.014) and a poor differentiation status (p=0.003) in 90 PDAC patients (Table 1, Fig. 2A, 2B and 2C). Here, CXCL5 is linked to neoplasm.